ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development--from compound selection to Phase I-IV clinical studies. ICON's broad range of specialized services span the entire life cycle of product development and can be adapted to suit small local trials or large global programs.